381 related articles for article (PubMed ID: 32086319)
1. TLR7 and TLR8 Differentially Activate the IRF and NF-κB Pathways in Specific Cell Types to Promote Inflammation.
Bender AT; Tzvetkov E; Pereira A; Wu Y; Kasar S; Przetak MM; Vlach J; Niewold TB; Jensen MA; Okitsu SL
Immunohorizons; 2020 Feb; 4(2):93-107. PubMed ID: 32086319
[TBL] [Abstract][Full Text] [Related]
2. Oligodeoxynucleotides differentially modulate activation of TLR7 and TLR8 by imidazoquinolines.
Gorden KK; Qiu X; Battiste JJ; Wightman PP; Vasilakos JP; Alkan SS
J Immunol; 2006 Dec; 177(11):8164-70. PubMed ID: 17114492
[TBL] [Abstract][Full Text] [Related]
3. TLR7 and TLR8 agonists trigger different signaling pathways for human dendritic cell maturation.
Larangé A; Antonios D; Pallardy M; Kerdine-Römer S
J Leukoc Biol; 2009 Apr; 85(4):673-83. PubMed ID: 19164127
[TBL] [Abstract][Full Text] [Related]
4. IRAK4 kinase activity controls Toll-like receptor-induced inflammation through the transcription factor IRF5 in primary human monocytes.
Cushing L; Winkler A; Jelinsky SA; Lee K; Korver W; Hawtin R; Rao VR; Fleming M; Lin LL
J Biol Chem; 2017 Nov; 292(45):18689-18698. PubMed ID: 28924041
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the neuroinflammatory response to TLR7 stimulation in the brain: comparison of multiple TLR7 and/or TLR8 agonists.
Butchi NB; Pourciau S; Du M; Morgan TW; Peterson KE
J Immunol; 2008 Jun; 180(11):7604-12. PubMed ID: 18490763
[TBL] [Abstract][Full Text] [Related]
6. TASL is the SLC15A4-associated adaptor for IRF5 activation by TLR7-9.
Heinz LX; Lee J; Kapoor U; Kartnig F; Sedlyarov V; Papakostas K; César-Razquin A; Essletzbichler P; Goldmann U; Stefanovic A; Bigenzahn JW; Scorzoni S; Pizzagalli MD; Bensimon A; Müller AC; King FJ; Li J; Girardi E; Mbow ML; Whitehurst CE; Rebsamen M; Superti-Furga G
Nature; 2020 May; 581(7808):316-322. PubMed ID: 32433612
[TBL] [Abstract][Full Text] [Related]
7. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.
Gorden KB; Gorski KS; Gibson SJ; Kedl RM; Kieper WC; Qiu X; Tomai MA; Alkan SS; Vasilakos JP
J Immunol; 2005 Feb; 174(3):1259-68. PubMed ID: 15661881
[TBL] [Abstract][Full Text] [Related]
8. A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells.
Gautier G; Humbert M; Deauvieau F; Scuiller M; Hiscott J; Bates EE; Trinchieri G; Caux C; Garrone P
J Exp Med; 2005 May; 201(9):1435-46. PubMed ID: 15851485
[TBL] [Abstract][Full Text] [Related]
9. Accessory-cell-mediated activation of porcine NK cells by toll-like receptor 7 (TLR7) and TLR8 agonists.
Toka FN; Nfon CK; Dawson H; Golde WT
Clin Vaccine Immunol; 2009 Jun; 16(6):866-78. PubMed ID: 19369481
[TBL] [Abstract][Full Text] [Related]
10. B cell autophagy mediates TLR7-dependent autoimmunity and inflammation.
Weindel CG; Richey LJ; Bolland S; Mehta AJ; Kearney JF; Huber BT
Autophagy; 2015; 11(7):1010-24. PubMed ID: 26120731
[TBL] [Abstract][Full Text] [Related]
11. IFNα enhances the production of IL-6 by human neutrophils activated via TLR8.
Zimmermann M; Arruda-Silva F; Bianchetto-Aguilera F; Finotti G; Calzetti F; Scapini P; Lunardi C; Cassatella MA; Tamassia N
Sci Rep; 2016 Jan; 6():19674. PubMed ID: 26790609
[TBL] [Abstract][Full Text] [Related]
12.
Yang BY; Cheng YG; Liu Y; Liu Y; Tan JY; Guan W; Guo S; Kuang HX
Molecules; 2019 Jun; 24(11):. PubMed ID: 31181689
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and immunological activities of novel Toll-like receptor 7 and 8 agonists.
Kandimalla ER; Struthers M; Bett AJ; Wisniewski T; Dubey SA; Jiang W; Precopio M; Sun Z; Wang H; Lan T; Agrawal S; Casimiro DR
Cell Immunol; 2011; 270(2):126-34. PubMed ID: 21570062
[TBL] [Abstract][Full Text] [Related]
14. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
[TBL] [Abstract][Full Text] [Related]
15. TLR7 and TLR8 activate distinct pathways in monocytes during RNA virus infection.
de Marcken M; Dhaliwal K; Danielsen AC; Gautron AS; Dominguez-Villar M
Sci Signal; 2019 Oct; 12(605):. PubMed ID: 31662487
[TBL] [Abstract][Full Text] [Related]
16. Interferon regulatory factor 5 and nuclear factor kappa-B exhibit cooperating but also divergent roles in the regulation of pro-inflammatory cytokines important for the development of TH1 and TH17 responses.
Stein T; Wollschlegel A; Te H; Weiss J; Joshi K; Kinzel B; Billich A; Guntermann C; Lehmann JCU
FEBS J; 2018 Aug; 285(16):3097-3113. PubMed ID: 29971953
[TBL] [Abstract][Full Text] [Related]
17. TLR7/8 agonists activate a mild immune response in rabbits through TLR8 but not TLR7.
Lai CY; Liu YL; Yu GY; Maa MC; Leu TH; Xu C; Luo Y; Xiang R; Chuang TH
Vaccine; 2014 Sep; 32(43):5593-9. PubMed ID: 25131730
[TBL] [Abstract][Full Text] [Related]
18. TLR7 and TLR8 gene variations and susceptibility to hepatitis C virus infection.
Wang CH; Eng HL; Lin KH; Chang CH; Hsieh CA; Lin YL; Lin TM
PLoS One; 2011; 6(10):e26235. PubMed ID: 22022576
[TBL] [Abstract][Full Text] [Related]
19. Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8.
Lan T; Kandimalla ER; Yu D; Bhagat L; Li Y; Wang D; Zhu F; Tang JX; Putta MR; Cong Y; Trombino AF; Sullivan T; Agrawal S
Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13750-5. PubMed ID: 17698957
[TBL] [Abstract][Full Text] [Related]
20. Differences in TLR7/8 activation between monocytes and macrophages.
Eng HL; Hsu YY; Lin TM
Biochem Biophys Res Commun; 2018 Feb; 497(1):319-325. PubMed ID: 29448098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
